Meg Jardine's Publications

• Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE

  Journal articles

  2020

  Journal of Nephrology

• No evidence of a legacy effect on survival following randomization to extended hours dialysis in the ACTIVE Dialysis trial

  Journal articles

  2020

  Nephrology

• Haemodialysis duration, frequency and intensity for end-stage kidney disease

  Journal articles

  2020

  Cochrane Database of Systematic Reviews

• The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: analysis of the CREDENCE trial

  Conference Abstracts

  2020

  DIABETOLOGIA

• Acute declines in eGFR during treatment with canagliflozin and its implications for clinical practice: insights from CREDENCE

  Conference Abstracts

  2020

  DIABETOLOGIA

• Cloth masks may prevent transmission of COVID-19: An evidence-based, risk-based approach

  Journal articles

  2020

  Annals of Internal Medicine

• Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial

  Conference Abstracts

  2020

  EUROPEAN HEART JOURNAL

• Comparative efficacy and safety of bp-lowering pharmacotherapy in patients undergoing maintenance dialysis: A network meta-analysis of randomized, controlled trials

  Journal articles

  2020

  Clinical Journal of the American Society of Nephrology

• Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop

  Conference Papers

  2020

  American Journal of Kidney Diseases

• A trial evaluating mid cut-off value membrane clearance of albumin and light chains in hemodialysis patients: A safety device study

  Journal articles

  2020

  Blood Purification

• Biomarkers of Tubular Injury and Effects of Canagliflozin in the CANVAS Trial

  Conference Abstracts

  2020

  DIABETES

• Acute Declines in EGFR during Treatment with Canagliflozin and Its Implications for Clinical Practice: Insights from CREDENCE

  Conference Presentations

  2020

• 1130-P: Mediators of the Effects of Canagliflozin (CANA) on Heart Failure (HF) and CV Death in Patients with Type 2 Diabetes (T2D) and Chronic Kidney Disease (CKD)

  Conference Posters

  2020

• EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM

  Conference Abstracts

  2020

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

  Conference Abstracts

  2020

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

  Conference Abstracts

  2020

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• 27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease

  Journal articles

  2020

  Diabetes

• P1028EFFECTS OF CANAGLIFLOZIN ON MAJOR ADVERSE CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIFFERENT BASELINE LEVELS OF TYPE 2 DIABETES MELLITUS DISEASE SEVERITY: RESULTS FROM THE CANVAS PROGRAM

  Journal articles

  2020

  Nephrology Dialysis Transplantation

• P1019CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

  Journal articles

  2020

  Nephrology Dialysis Transplantation

• P1013CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL

  Journal articles

  2020

  Nephrology Dialysis Transplantation

• Predictors of Change in Left-Ventricular Structure and Function in a Trial of Extended Hours Hemodialysis

  Journal articles

  2020

  Journal of Cardiac Failure

• The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.

  Journal articles

  2020

  Diabetes Obes Metab

• Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: A secondary analysis of the CREDENCE randomized trial

  Journal articles

  2020

  Journal of the American Society of Nephrology

• Incidence and associations of chronic kidney disease in community participants with diabetes: A 5-year prospective analysis of the EXTEND45 study

  Journal articles

  2020

  Diabetes Care

• Impact of supplemental private health insurance on dialysis and outcomes

  Journal articles

  2020

  Internal Medicine Journal

• Examining outcomes in chronic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study

  Journal articles

  2020

  JMIR Research Protocols